EXPE
58
5
DE
53
-2
PWR
60
2
GWW
37
-2
MTCH
53
2
RCL
69
3
MA
43
2
CHD
34
3
NTRS
65
3
HES
56
2
SIG
44
4
ABT
35
-7
AXP
66
2
ALLE
44
14
HAL
50
4
FE
37
2
VRSK
38
5
NDAQ
70
3
HUM
31
-11
KO
50
6
EXPE
58
5
DE
53
-2
PWR
60
2
GWW
37
-2
MTCH
53
2
RCL
69
3
MA
43
2
CHD
34
3
NTRS
65
3
HES
56
2
SIG
44
4
ABT
35
-7
AXP
66
2
ALLE
44
14
HAL
50
4
FE
37
2
VRSK
38
5
NDAQ
70
3
HUM
31
-11
KO
50
6
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$21.85
Seasonality Move:
-4.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 0.8% based on the past 10 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $21.88. The Score for BBC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 0.8% based on the past 10 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Buy
57
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Buy

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.65
52-Week Low:
13.42

Prediction Charts

Market Cap:
0
Price in USD:
21.88
Volume:
10.7K
Beta:
1.28

Technical Analysis

SMA50:
19.33
SMA100:
18.92
SMA200:
22.49
52-Wk Change:
-24.81%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 21.88 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-27 19.75 19.41 19.79 19.31
Jun-30 19.49 19.32 19.60 19.31
Jul-1 19.25 19.46 19.96 19.15
Jul-2 19.43 20.19 20.41 19.43
Jul-3 20.27 20.32 20.39 20.08
Jul-7 20.33 19.99 20.33 19.87
Jul-8 20.23 20.33 20.55 20.21
Jul-9 20.61 21.59 21.69 20.61
Jul-10 21.45 21.53 21.60 21.02
Jul-11 21.35 21.19 21.45 21.19
Jul-14 21.31 21.70 21.81 21.30
Jul-15 21.68 21.07 21.76 21.00
Jul-16 21.41 21.60 21.60 21.09
Jul-17 21.78 21.88 22.04 21.73

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.